Sun Pharmaceutical Industries Limited (BOM: 524715)

Sun Pharmaceutical Industries Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 19, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	4,340,037	3,888,242	2,358,729	2,194,737	1,434,322	845,286
Market Cap Growth	66.29%	64.84%	7.47%	53.02%	69.68%	-26.43%
Enterprise Value	4,167,182	3,792,904	2,296,495	2,136,376	1,424,670	852,641
Last Close Price	1808.50	1615.38	971.01	893.87	577.83	336.96
PE Ratio	39.26	40.60	27.84	67.06	49.39	22.45
PS Ratio	9.19	8.02	5.37	5.68	4.28	2.57
PB Ratio	6.66	5.79	3.98	4.30	2.90	1.72
P/TBV Ratio	9.08	8.38	6.16	6.23	4.16	2.61
P/FCF Ratio	42.91	39.14	82.08	29.30	28.69	16.86
P/OCF Ratio	36.36	32.04	47.56	24.43	23.25	12.90
EV/Sales Ratio	8.28	7.82	5.23	5.53	4.25	2.60
EV/EBITDA Ratio	29.94	29.46	19.71	21.04	17.07	12.44
EV/EBIT Ratio	36.46	36.05	24.68	26.19	22.16	17.23
EV/FCF Ratio	38.68	38.18	79.91	28.52	28.49	17.01
Debt / Equity Ratio	0.04	0.05	0.12	0.03	0.08	0.17
Debt / EBITDA Ratio	0.18	0.25	0.58	0.13	0.46	1.20
Debt / FCF Ratio	0.24	0.33	2.40	0.17	0.77	1.66
Asset Turnover	0.60	0.58	0.58	0.56	0.49	0.49
Inventory Turnover	1.13	1.08	1.12	1.17	1.05	1.17
Quick Ratio	1.92	1.82	1.36	1.37	1.20	1.36
Current Ratio	2.67	2.56	2.00	2.03	1.89	2.02
Return on Equity (ROE)	16.77%	15.20%	15.42%	6.74%	4.61%	8.89%
Return on Assets (ROA)	8.54%	7.91%	7.73%	7.42%	5.91%	4.65%
Return on Capital (ROIC)	10.44%	9.63%	9.81%	9.64%	7.25%	5.49%
Earnings Yield	2.55%	2.46%	3.59%	1.49%	2.02%	4.45%
FCF Yield	2.33%	2.55%	1.22%	3.41%	3.49%	5.93%
Dividend Yield	0.75%	0.84%	1.18%	1.12%	1.30%	1.19%
Payout Ratio	28.39%	30.26%	29.73%	65.97%	53.70%	36.63%
Buyback Yield / Dilution	0.14%	-	-	-	-	-0.00%
Total Shareholder Return	0.88%	0.84%	1.18%	1.12%	1.30%	1.19%

Source: S&P Capital IQ. Standard template. Financial Sources.